Mostrando ítems 171-178 de 178
Olea, Rodica-Alis (Fecha de defensa: 2024-01-15)
[eng] In the last decades, great research effort was focused towards designing nanocarriers for cancer therapy. However, nanoparticle translation from basic research to the clininc has proven to be a ...
Playà Albinyana, Heribert (Fecha de defensa: 2024-04-29)
[eng] Chronic lymphocytic leukemia (CLL) is a prevalent form of leukemia among adults in western countries, marked by a monoclonal mature CD19+ CD5+ B cell expansion in the peripheral blood, secondary ...
Garcia Garijo, Andrea (Fecha de defensa: 2023-05-26)
[eng] Adoptive cell transfer (ACT) of tumor-infiltrating lymphocytes (TILs) can medi- ate tumor regression in patients with metastatic melanoma. Retrospective studies of TIL products from responders and ...
Hernández Carro, Claudia (Fecha de defensa: 2024-03-19)
[eng] Prostate and colorectal cancer are among the cancer types with the highest recurrence and mortality rates. The emergence of drug resistance poses a considerable challenge for effective treatment, ...
Creus Bachiller, Edgar (Fecha de defensa: 2024-03-13)
[eng] Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are aggressive soft-tissue sarcomas. They usually appear in the clinical context of Neurofibromatosis type 1 (NF1), however, they also occur at a ...
Aguado Flor, Ester (Fecha de defensa: 2024-04-12)
[eng] During radiotherapy (RT) some healthy tissues are irradiated inevitably causing side effects, without being able to predict nowadays which patients will develop this toxicity. To date, the biomarker ...
Monserrat Vicente, Laia (Fecha de defensa: 2024-01-12)
[eng] Breast cancer (BC) is the most diagnosed cancer in women and the second leading cause of cancer-related deaths in this population. Luminal BC accounts for 70% of tumours and is characterised by ...
Arce Gallego, Sara (Fecha de defensa: 2024-01-19)
[eng] Prostate cancer is the second most prevalent cancer among men. While early-stage has low mortality rates, metastatic castration-resistant prostate cancer (mCRPC) is a lethal form of the disease ...